Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a Pasadena, California-based biotechnology and pharmaceuticals company developing RNA interference medicines that silence disease-causing genes. It uses its proprietary Targeted RNAi Molecule (TRiM) platform for drug discovery and tissue-targeted delivery. Its commercial product REDEMPLO (plozasiran) is approved in the United States for adults with familial chylomicronemia syndrome, while its pipeline includes investigational cardiometabolic, pulmonary and other RNAi therapies.
Key facts
| Legal Name | Arrowhead Pharmaceuticals, Inc. |
|---|---|
| Company Operating Status | Active |
| Full Address | 177 East Colorado Boulevard, Suite 700 Pasadena, CA 91105 |
| Motto/Tagline | Target the Gene, Silence the Disease |
| Previous Name | ARROWHEAD RESEARCH CORP |
| Stock Symbol | ARWR |
| Ticker Symbol | ARWR |
| Wellfound ID | arrowhead-pharmaceuticals |
| Wikidata ID | Q22121863 |
Contact details
Email and phone for Arrowhead Pharmaceuticals are available to signed-in members of CliffBio.
Sign in to view